| abstract |
(57) [Summary]nThe present invention relates to newly identified pancreatic or pancreatic cancer-related polynucleotides, and the polypeptides encoded by these polynucleotides, collectively referred to herein as "pancreatic cancer antigens". To the use of such pancreatic cancer antigens for detecting, preventing and treating the presence of pancreatic disorders, especially pancreatic cancer. The present invention relates to pancreatic cancer antigens, and vectors, host cells, antibodies to pancreatic cancer antigens, and methods for their production by recombination and synthesis. Also provided are diagnostic methods for diagnosing and treating, preventing, and / or prognosing pancreatic-related disorders, including pancreatic cancer, and therapeutic methods for treating such disorders. |